SCHEMBL8417636

SCHEMBL8417636

COc1cccc(N2CCN(CCCCn3cc(Cl)cn3)CC2)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.69
HTR1A P08908 6/20 0.59
DRD2 P14416 5/20 0.59
DRD4 P21917 4/20 0.59
HTR2A P28223 2/20 0.59
HTR7 P34969 2/20 0.59
ADRA2A P08913 1/20 0.59
ADRA2C P18825 1/20 0.59
HRH2 P25021 1/20 0.59
HTR1B P28222 1/20 0.59
ADRA1A P35348 1/20 0.59
HRH1 P35367 1/20 0.59
ADRA1B P35368 1/20 0.59
HTR2B P41595 1/20 0.59
SIGMAR1 Q99720 1/20 0.59
KDM4E B2RXH2 1/20 0.56
ALDH1A1 P00352 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
CACNA1G O43497 2/20 0.54
MAPT P10636 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8416326 0.87 HSD17B10 (0.57) KCNH2HTR1ADRD2DRD4HTR2A
SCHEMBL8419627 0.87 KCNH2 (0.71) KCNH2HTR1ADRD2DRD4HTR2A
SCHEMBL8416487 0.83 KCNH2 (0.60) KCNH2HTR1ADRD2DRD4HTR2A
SCHEMBL4524281 0.82 KCNH2 (1.00) KCNH2HTR1ADRD2DRD4KDM4E
SCHEMBL4525293 0.82 KCNH2 (1.00) KCNH2HTR1ADRD2DRD4HTR2A
SCHEMBL8416458 0.81 SIGMAR1 (0.59) KCNH2HTR1ADRD2HTR2AHTR7
SCHEMBL8416526 0.79 HTR1A (0.62) HTR1ADRD2DRD4HTR2AHTR7
SCHEMBL13711973 0.78 KCNH2 (0.87) KCNH2DRD2DRD4KDM4EALDH1A1
SCHEMBL10835591 0.78 KCNH2 (0.81) KCNH2HTR1ADRD2DRD4HTR2A
SCHEMBL3198597 0.77 KCNH2 (0.84) KCNH2HTR1ADRD2DRD4HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0655248-B1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion ESTEVE LABOR DR (ES) 1999-09-15 EP claimed
US-5532234-A Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion LABORATORIES DEL DR. ESTEVE, S.A. (ES) 1996-07-02 US claimed
EP-0502786-B1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives ESTEVE LABOR DR (ES) 1996-04-24 EP claimed
EP-0497659-B1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs ESTEVE LABOR DR (ES) 1996-04-10 EP claimed
EP-0497659-A1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-08-05 EP claimed